Transaction DateRecipientSharesTypePriceValue
17th November 2020Jonathan Will Mc Guire104,254Grant/award etc.$0.00
3rd August 2020Jonathan Will Mc Guire10,000Open or private purchase$0.35$3,500.00
22nd May 2020Jonathan Will Mc Guire10,000Open or private purchase$0.46$4,648.00
19th May 2020Jonathan Will Mc Guire3,357Sale back to the issuer$5.29$17,758.53
30th March 2020Jonathan Will Mc Guire125,000Grant/award etc.$0.00
20th February 2020John T Blake809Sale back to the issuer$5.44$4,400.96
20th February 2020William Patrick Ryan1,133Sale back to the issuer$5.84$6,616.72
20th February 2020Jonathan Will Mc Guire1,793Open or private sale$5.44$9,753.92
19th February 2020John T Blake2,563Grant/award etc.$0.00
19th February 2020William Patrick Ryan3,594Grant/award etc.$0.00
Second Sight Medical Products
Second Sight Medical Products logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.

Second Sight Medical Products, Inc. was founded in 1998 and is headquartered in Sylmar, CA. Its product, the Argus II Retinal Prosthesis System, treats outer retinal degenerations.

Ticker: EYES
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1266806
Employees: 112
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags